Following representations made by Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024.
On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured by CNX Therapeutics Ltd. Under the current price change mechanism, the new list prices would only apply to reimbursement for NHS prescriptions dispensed from May 2024.
To avoid pharmacy contractors dispensing these products at a loss, DHSC has granted the following reimbursement price changes for the dispensing month of April 2024. The retrospective price adjustments will apply to both branded and generically written prescriptions for lurasidone tablets.
Generic name
Brand name
Pack size
Previous reimbursement price
Retrospectively adjusted reimbursement price (effective from April 2024)
Lurasidone 18.5mg tablets
Latuda® 18.5mg tablets
28
£37.60
£80.00
Lurasidone 37mg tablets
Latuda® 37mg tablets
28
£37.60
£80.00
Lurasidone 74mg tablets
Latuda® 74mg tablets
28
£37.60
£80.00
The post Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024 appeared first on Community Pharmacy England.